Effects of σ1 receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats

European Journal of Pharmacology

Volumn 402, Issue 3, 2000, Pages 251-254

  Yamada, Shigeto ^a   Yamauchi, Kohji ^a   Hisatomi, Shinji ^a   Annoh, Naoko ^a   Tanaka, Masatoshi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apomorphine; MS 377; Phencyclidine; Prepulse inhibition; 1 Receptor ligand

Indexed keywords

1 (4 CHLOROPHENYL) 3 [4 (2 METHOXETHYL)PIPERAZIN 1 YL]METHYL 2 PYRROLIDINONE LEVO TARTRATE; 1 (4 CHLOROPHENYL) 3 [4 (2 METHOXYETHYL)PIPERAZIN 1 YL]METHYL 2 PYRROLIDINONE TARTRATE; APOMORPHINE; NEUROLEPTIC AGENT; PHENCYCLIDINE; SIGMA RECEPTOR LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

5-HYDROXYTRYPTOPHAN; ACOUSTIC STIMULATION; ANIMALS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; DOPAMINE AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; PHENCYCLIDINE; PIPERAZINES; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, SIGMA; STARTLE REACTION; TARTRATES;

EID: 0034714311     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00498-2     Document Type: Article

References (23)

1. Bakshi V.P., Geyer M.A. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine. Psychopharmacology. 122:1995;198-201.
2. Bakshi V.P., Geyer M.A. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an α-1 noradrenergic antagonist. J. Pharmacol. Exp. Ther. 283:1997;666-674.
3. Bakshi V.P., Swerdlow N.R., Geyer M.A. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther. 271:1994;787-794.
4. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
5. Clissold D.B., Pontecorvo M.J., Jones B.E., Abreu M.E., Karbon E.W., Erickson R.H., Natalie K.J., Borosky S., Hartman T., Mansbach R.S., Balster R.L., Ferkany J.W., Enna S.J. NPC 16377, a potent and selective σ-ligand. II. Behavioral and neuroprotective profile J. Pharmacol. Exp. Ther. 265:1992;876-886.
6. Curzon P., Decker M.W. Effects of phencyclidine (PCP) and (+)-MK801 on sensorimotor gating in CD-1 mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 22:1998;129-146.
7. Graham F. The more or less startling effects of weak prestimulation. Psychophysiology. 12:1975;238-248.
8. Gundlach A.L., Largent B.L., Snyder S.H. Phencyclidine and sigma receptors in the brain: biochemical and autoradiographical differentiation. Eur. J. Pharmacol. 113:1985;465-466.
9. Helmeste D.M., Tang S.W., Bunney W.E., Potkin S.G., Jones E.G. Decrease in σ but no increase in striatal dopamine D4 receptors in schizophrenic brain. Eur. J. Pharmacol. 314:1996;R3-R5.
10. Hori T., Suzuki T., Baba A., Abe S., Yamamoto T., Moroji T., Shiraishi H. Effects of phencyclidine metabolites on serotonin uptake in rat brain. Neurosci. Lett. 209:1996;153-156.
11. Johansson C., Jackson D.M., Zhang J., Svensson L. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol. Biochem. Behav. 52:1994;649-654.
12. Kodsi M.H., Swerdlow N.R. Ventral pallidal GABA-A receptors regulate prepulse inhibition of acoustic startle. Brain Res. 684:1995;26-35.
13. Lipska B.K., Swerdlow N.R., Geyer M.A., Jaskiw G.E., Braff D.L., Weinberger D.R. Neonatal excitotoxic hippocampal damage in rats caused post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 122:1995;35-43.
14. Matos F.F., Korpinen C., Yocca F.D. 5-HT1A receptor agonists of BMY-14802 on serotonin release in dorsal raphe and hippocampus. Eur. J. Pharmacol. 317:1996;49-54.
15. Okuyama S., Imagawa Y., Ogawa S., Araki H., Ajima A., Tanaka M., Muramatsu M., Nakazato A., Yamaguchi K., Yoshida M., Otomo S. NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci. 53:1993;285-290.
16. Ohno Y., Warnick J.E. Presynaptic activation of the spinal serotonergic system in the rat by phencyclidine in rat. J. Pharm. Exp. Ther. 250:1989;177-183.
17. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficit sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry. 51:1994;139-154.
18. Swerdlow N.R., Bakshi V., Geyer M.A. Seroquel restores sensorimotor gating in phencyclidine-treated rats. J. Pharmacol. Exp. Ther. 279:1996;1290-1299.
19. Takahashi S., Sonehara K., Takagi K., Miwa T., Horikomi K., Mita N., Nagase H., Iizuka K., Sakai K. Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors. Psychopharmacology. 145:1999;295-302.
20. 3H)haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. U.S.A. 81:1984;5618-5621.
21. Wan F.J., Geyer M.A., Swedlow N.R. Presynaptic dopamine-glutamate interaction in the nucleus accumbens regulates sensorimotor gating. Psychopharmacology. 120:1995;433-441.
22. Yamada S., Harano M., Annoh N., Nakamura K., Tanaka M. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats. Biol. Psychiatry. 46:1999;832-838.
23. 3H)-cyclazocine binding to multiple receptor sites. Mol. Pharmacol. 20:1981;246-254.